These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38346952)

  • 21. Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses.
    Skarlupka AL; Owino SO; Suzuki-Williams LP; Crevar CJ; Carter DM; Ross TM
    Hum Vaccin Immunother; 2019; 15(9):2013-2029. PubMed ID: 31448974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
    Moin SM; Boyington JC; Boyoglu-Barnum S; Gillespie RA; Cerutti G; Cheung CS; Cagigi A; Gallagher JR; Brand J; Prabhakaran M; Tsybovsky Y; Stephens T; Fisher BE; Creanga A; Ataca S; Rawi R; Corbett KS; Crank MC; Karlsson Hedestam GB; Gorman J; McDermott AB; Harris AK; Zhou T; Kwong PD; Shapiro L; Mascola JR; Graham BS; Kanekiyo M
    Immunity; 2022 Dec; 55(12):2405-2418.e7. PubMed ID: 36356572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection.
    Zeng D; Xin J; Yang K; Guo S; Wang Q; Gao Y; Chen H; Ge J; Lu Z; Zhang L; Chen J; Chen Y; Xia N
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
    Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model.
    Roubidoux EK; Carreño JM; McMahon M; Jiang K; van Bakel H; Wilson P; Krammer F
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.
    Muramatsu M; Yoshida R; Miyamoto H; Tomabechi D; Kajihara M; Maruyama J; Kimura T; Manzoor R; Ito K; Takada A
    PLoS One; 2013; 8(8):e71534. PubMed ID: 23977065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells.
    Ursin RL; Dhakal S; Liu H; Jayaraman S; Park HS; Powell HR; Sherer ML; Littlefield KE; Fink AL; Ma Z; Mueller AL; Chen AP; Seddu K; Woldetsadik YA; Gearhart PJ; Larman HB; Maul RW; Pekosz A; Klein SL
    mBio; 2022 Aug; 13(4):e0183922. PubMed ID: 35856618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    Reneer ZB; Jamieson PJ; Skarlupka AL; Huang Y; Ross TM
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo.
    Edgar JE; Trezise S; Anthony RM; Krammer F; Palese P; Ravetch JV; Bournazos S
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2314905120. PubMed ID: 37871218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice.
    Bliss CM; Freyn AW; Caniels TG; Leyva-Grado VH; Nachbagauer R; Sun W; Tan GS; Gillespie VL; McMahon M; Krammer F; Hill AVS; Palese P; Coughlan L
    Mol Ther; 2022 May; 30(5):2024-2047. PubMed ID: 34999208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine.
    Li Z; Zaiser SA; Shang P; Heiden DL; Hajovsky H; Katwal P; DeVries B; Baker J; Richt JA; Li Y; He B; Fang Y; Huber VC
    Vet Microbiol; 2020 Nov; 250():108859. PubMed ID: 33039727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.
    Kawai A; Yamamoto Y; Nogimori T; Takeshita K; Yamamoto T; Yoshioka Y
    J Virol; 2021 Sep; 95(20):e0118021. PubMed ID: 34379511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One HA stalk topping multiple heads as a novel influenza vaccine.
    Zhou P; Qiu T; Wang X; Yang X; Shi H; Zhu C; Dai W; Xing M; Zhang X; Xu J; Zhou D
    Emerg Microbes Infect; 2024 Dec; 13(1):2290838. PubMed ID: 38044872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.